Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN-I production following viral infection

Nat Commun. 2025 Feb 7;16(1):1460. doi: 10.1038/s41467-025-56603-5.

Abstract

Type I Interferons (IFN-I) are central to host protection against viral infections, with plasmacytoid dendritic cells (pDC) being the most significant source, yet pDCs lose their IFN-I production capacity following an initial burst of IFN-I, resulting in susceptibility to secondary infections. The underlying mechanisms of these dynamics are not well understood. Here we find that viral infection reduces the capacity of pDCs to engage both oxidative and glycolytic metabolism. Mechanistically, we identify lactate dehydrogenase B (LDHB) as a positive regulator of pDC IFN-I production in mice and humans; meanwhile, LDHB deficiency is associated with suppressed IFN-I production, pDC metabolic capacity, and viral control following infection. In addition, preservation of LDHB expression is sufficient to partially retain the function of otherwise exhausted pDCs, both in vitro and in vivo. Furthermore, restoring LDHB in vivo in pDCs from infected mice increases IFNAR-dependent, infection-associated pathology. Our work thus identifies a mechanism for balancing immunity and pathology during viral infections, while also providing insight into the highly preserved infection-driven pDC inhibition.

MeSH terms

  • Animals
  • Dendritic Cells* / immunology
  • Dendritic Cells* / metabolism
  • Female
  • Glycolysis
  • Humans
  • Interferon Type I* / immunology
  • Interferon Type I* / metabolism
  • L-Lactate Dehydrogenase* / genetics
  • L-Lactate Dehydrogenase* / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptor, Interferon alpha-beta / genetics
  • Receptor, Interferon alpha-beta / metabolism
  • Virus Diseases* / immunology
  • Virus Diseases* / metabolism

Substances

  • Interferon Type I
  • L-Lactate Dehydrogenase
  • Receptor, Interferon alpha-beta